Next Article in Journal
A Comparative Analysis of Stress Relief, Life Satisfaction, and Quality of Life Based on Marriage Status and Gender Among Members of Society Participating in Exercise
Previous Article in Journal
Narcissism and Anti-Immigrant Attitudes: A Tale of Pride and Prejudice?
Previous Article in Special Issue
A Systematic Literature Review of Soft Skills in Information Technology Education
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Integrated Cognitive Remediation and Recovery-Oriented Program for Individuals with Bipolar Disorder Using a Virtual Reality-Based Intervention: 6- and 12-Month Cognitive Outcomes from a Randomized Feasibility Trial

1
Department of Medical Sciences and Public Health, University of Cagliari, 09124 Cagliari, Italy
2
Department of Neuroscience, University of Turin, 10125 Turin, Italy
3
Department of Systems Medicine, University of Tor Vergata, 00133 Rome, Italy
4
Cerebrum VR Society, 00185 Rome, Italy
5
IDEGO Digital Psychology Society, 00133 Rome, Italy
6
Centre of Neuroscience, Neurodiversity Institute, Queimados 26325-010, Brazil
7
Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro 22290-140, Brazil
*
Author to whom correspondence should be addressed.
Behav. Sci. 2025, 15(4), 452; https://doi.org/10.3390/bs15040452
Submission received: 24 December 2024 / Revised: 17 March 2025 / Accepted: 28 March 2025 / Published: 1 April 2025
(This article belongs to the Special Issue Psychoeducation and Early Intervention)

Abstract

:
Introduction: Achieving long-term impacts from cognitive remediation (CR) interventions is a key goal in rehabilitative care. Integrating virtual reality (VR) with psychoeducational approaches within CR programs has shown promise in enhancing user engagement and addressing the complex needs of individuals with bipolar disorder (BD). A previous randomized controlled crossover feasibility trial demonstrated the viability of a fully immersive VR-CR intervention for BD, reporting low dropout rates, high acceptability, and significant cognitive improvements. This secondary analysis aimed to evaluate the stability of these outcomes over time. Methods: This paper presents a 6- to 12-month follow-up of the initial trial. Secondary cognitive outcomes were assessed, including visuospatial abilities, memory, attention, verbal fluency, and executive function, using validated assessment tools. Statistical analyses were conducted using Friedman’s test. Results: A total of 36 participants completed the 6- to 12-month follow-up. Overall, cognitive functions showed a trend toward stability or improvement over time, except for visuospatial and executive functions, which demonstrated inconsistent trajectories. Significant improvements were observed in language (p = 0.02). Conclusion: This study highlights the overall stability of cognitive functions 12 months after a fully immersive VR-CR program for individuals with BD. To sustain long-term clinical benefits, an integrated approach, such as incorporating psychoeducational strategies within cognitive remediation interventions, may be essential. Further follow-up studies with control groups and larger sample sizes are needed to validate these findings.

1. Introduction

Bipolar disorder (BD) is one of the leading causes of global disability (Carta et al., 2021; Whiteford et al., 2013; Vieta et al., 2018). It is frequently associated with cognitive impairment (CI), affecting a significant proportion of individuals diagnosed with BD (Douglas et al., 2018). CI is strongly linked to poor recovery in personal, social, and occupational functioning (Bortolato et al., 2015; Ehrminger et al., 2021). Therefore, improving CI is a critical therapeutic target in BD treatment (Miskowiak et al., 2017; Tsapekos et al., 2023). Given its multifactorial nature, CI in BD requires integrated and complex interventions for effective management (Samamé, 2024).
Cognitive remediation (CR) is a well-established intervention aimed at enhancing cognitive functioning and improving daily life in individuals with mental health conditions, including BD. Importantly, CR promotes long-term functional recovery by addressing cognitive deficits (Tsapekos et al., 2022). Traditionally, validated CR interventions include paper-based and computerized methods (Cella et al., 2017). Recent studies have demonstrated that conventional CR approaches for individuals with BD lead to significant cognitive improvements (Lewandowski et al., 2017; Bernabei et al., 2020; Strawbridge et al., 2021). Functional remediation (FR) is an adaptation of standard CR that was specifically designed for BD. This approach addresses cognitive deficits within an ecological framework, integrating psychoeducation on neuropsychological impairments and their impact on daily life (Torrent et al., 2013; Samamé et al., 2023; Perra et al., 2023a). FR facilitates the incorporation of various rehabilitative strategies within CR sessions, enabling the development of comprehensive interventions aligned with the biopsychosocial model (Perra et al., 2023b; Fiorillo & Giordano, 2022). This integrative approach is consistent with the latest framework for designing complex interventions (Skivington et al., 2021).
Although further high-quality studies on BD are needed, the demonstrated efficacy of CR highlights is potential as a valuable therapeutic tool for improving CI, which, in turn, impacts psychosocial functioning (Tsapekos et al., 2022; Samamé et al., 2023).
However, studies on the effectiveness of CR in BD face several limitations. These include high variability in cognitive and psychosocial outcomes, methodological weaknesses such as small sample sizes, study designs that lack adequate statistical power, higher dropout rates with paper-and-pencil methods compared to other populations, and the absence of a structured framework, which limits intervention reproducibility (Tsapekos et al., 2022; Perra et al., 2023b). Additionally, the lack of long-term follow-up studies prevents a comprehensive evaluation of CR’s sustained effects, despite its critical role in rehabilitation (Zhu et al., 2022; Deste et al., 2015). These factors hinder a clear understanding of the variables influencing treatment outcomes. Naturally, the results may be affected by the study design, methodological choices, and intervention quality. Furthermore, characteristics related to the intervention type and implementation also play a crucial role (Wykes et al., 2011; Tsapekos et al., 2022). In particular, CR interventions require a robust theoretical framework to ensure a structured and targeted approach that aligns with specific clinical needs (Perra et al., 2023b; Skivington et al., 2021).
A well-defined session structure enhances intervention reproducibility. Research involving other populations, such as individuals with schizophrenia, has highlighted the pivotal role of the therapist in CR sessions. Strategies that facilitate the transfer of cognitive improvements to real-world contexts are essential for aligning with personal recovery goals. These strategies include discussion-based sessions, role playing, and out-of-session tasks such as homework assignments (Tsapekos et al., 2022). Certain CR methodologies emphasize the integration of these strategies to foster metacognitive development (Cella et al., 2015).
Moreover, studies suggest that therapist involvement is critical in promoting adherence and reducing dropout rates in CR interventions (Huddy et al., 2012). Additionally, intensive cognitive training (massed practice) has been linked to greater neural network engagement and improved cognitive outcomes (Vinogradov et al., 2012). A particularly relevant finding in BD research is the presence of a dose–response relationship, where a higher number of CR sessions correlates with greater cognitive and functional improvements. Completing at least 20 sessions has been associated with substantial treatment benefits. In schizophrenia research, an optimal CR session frequency has been estimated at 2.5 sessions per week (Vita et al., 2021), although maintaining at least two sessions per week remained effective (Reeder et al., 2017).
Beyond methodological considerations, recent years have seen a growing interest of immersive technologies, such as virtual reality (VR), in rehabilitative interventions (Valmaggia, 2017; Freeman et al., 2019). The integration of fully immersive VR-based CR may enhance user engagement, particularly in individuals with BD, and facilitate the transfer of learned skills to daily life (Freeman et al., 2017; Perra et al., 2023a). Given BD’s characteristic exploratory behavior and hyperactivity (Carta et al., 2023a), VR-based interventions could provide an engaging and playful yet effective rehabilitation approach.
To explore these aspects, a randomized controlled crossover feasibility trial was conducted following established CR methodologies (Perra et al., 2022). The primary objective was to evaluate feasibility outcomes, including acceptability, tolerability (dropout rates), satisfaction, and potential side effects. The secondary objective was to gather preliminary data on effectiveness. Specifically, the study assessed cognitive domains (attention, memory, executive functions, language, and visuospatial skills) and psychosocial variables relevant to BD, such as depressive and anxiety symptoms, quality of life, biological rhythms, and emotional awareness. Cognitive impairment in BD significantly impacts quality of life and contributes to biological and social rhythm dysregulation (Carta et al., 2022, 2023b, 2023c).
The post-treatment results (Perra et al., 2023a) demonstrated the feasibility of a fully immersive VR-CR intervention for BD, with low dropout rates, high acceptability, and high satisfaction levels, consistent with previous studies (Tsapekos et al., 2022 2023. Additionally, the preliminary evidence suggested significant cognitive and psychosocial improvements following the VR-CR intervention.

Aim

This study represents a secondary analysis of a previously conducted randomized controlled crossover feasibility trial. The objective was to evaluate the stability of the cognitive function outcomes at 6- and 12-month follow-ups after completing a fully immersive VR-CR program that incorporated an integrated psychoeducational approach.

2. Materials and Methods

2.1. Study Design

This study was a 6- and 12-month follow-up of a previous randomized controlled crossover feasibility trial (Perra et al., 2022). Due to the crossover design, a control group was not available for the 6- and 12-month follow-ups. The original study adhered to the reporting standards outlined in the CONSORT extension for feasibility studies (Eldridge et al., 2016) and was registered on ClinicalTrials.gov in September 2021 under protocol number NCT05070065.

2.2. Participants and Simple Size Considerations

Among the 50 individuals with BD who participated in the previous study (Perra et al., 2023a), 36 were evaluated 6 and 12 months after the intervention (t2, t3), as shown in the flow diagram (Figure 1). The participants were recruited from the Consultation Psychiatry and Psychosomatic Center at the University Hospital of Cagliari. The dropout rate was 22% post-treatment, as previously reported (Perra et al., 2023a). All inclusion and exclusion criteria details are provided elsewhere (Perra et al., 2023a). Briefly, the inclusion criteria were individuals aged 18 to 75 years, a diagnosis of BD, and inclusion of both sexes. The exclusion criteria included individuals experiencing manic/depressive episodes, those diagnosed with epilepsy, or those with severe ocular conditions due to the potential risks associated with VR stimulation. Regarding the sample size, an initial estimate targeted 60 participants to assess the feasibility outcomes and provide preliminary efficacy data for the VR intervention. However, given the limited evidence in this research area, a precise sample size calculation was not feasible (Ott et al., 2021; Goldberg et al., 2023). The final sample comprised 50 participants due to the early cessation of the enrollment caused by the COVID-19 pandemic. The primary aim remained assessing the feasibility and gathering preliminary efficacy data, with a more detailed sample size calculation planned for the efficacy study based on Phase II data (Abdulatif et al., 2015).

2.3. Outcomes and Data Collection

The previous study, a Phase 2 feasibility study, primarily assessed feasibility, while the secondary outcomes included a preliminary evaluation of efficacy in terms of cognitive and psychosocial variables (personal and social functioning, levels of anxiety, depressive symptoms, alexithymia, quality of life, and biological and social rhythms). For the present study, the cognitive outcomes, previously considered secondary, were the primary focus. The cognitive functions assessed included visuospatial abilities, attention, memory, verbal and semantic fluency, and executive function. Assessments were conducted at baseline (pre-treatment), immediately post-treatment, and after 6 and 12 months using validated and standardized cognitive assessment tools in their Italian versions. These tools are widely used in psychiatric literature for evaluating cognitive deficits in BD (Ehrlich et al., 2022; Lima et al., 2019), allowing for a comprehensive analysis of individual performance across cognitive subdomains to support personalized cognitive training.
-
Visuospatial function: Rey Figure Test (Caffarra et al., 2002a);
-
Attention and immediate recall: Matrix Test (Spinnler & Tognoni, 1987) and Rey’s Words Test (Caltagirone et al., 1995);
-
Attention function: Forward Digit Span (Orsini et al., 1987; Bisiacchi et al., 2003) and Trail Making Test, Part A (Spinnler & Tognoni, 1987; Giovagnoli et al., 1996);
-
Memory function: Rey’s Words Test Delayed Recall (Caltagirone et al., 1995), Test of the Tale (Carlesimo et al., 2002), and Backward Digit Span (Orsini et al., 1987; Bisiacchi et al., 2003);
-
Language function: Phonological and Semantic Verbal Fluency Test, both versions (Carlesimo et al., 2002; Novelli et al., 1986);
-
Executive function: Digital Symbol Substitution Test (Amodio et al., 2002, 2008), Trail Making Test, Part B (Amodio et al., 2008), Stroop Test (Caffarra et al., 2002b), Frontal Assessment Battery (FAB) (Dubois et al., 2000), and Cognitive Estimates Test (CET) (Scarpina et al., 2015; Della Sala et al., 2003).

2.4. Intervention

The experimental group underwent the fully immersive VR-CR intervention using “CEREBRUM” software (version 3.0.1), developed by the Cerebrum VR Society (Rome, Italy). This software is among the latest tools in psychiatric rehabilitation that was specifically designed for CR. Created by mental health professionals, CEREBRUM is compatible with the “Oculus Quest” VR headset, which bears the CE mark, ensuring compliance with European safety, health, and environmental protection standards. The software enables training in various cognitive functions through exercises of increasing difficulty. Within the immersive virtual environment, the participants engaged with scenarios simulating both domestic and urban life. The intervention lasted three months, with 2 sessions per week, totaling 24 sessions.
To ensure clarity and facilitate replication, the logical framework guiding the study’s objectives was outlined in previous publications (Perra et al., 2022, 2023a). The intervention was conceptualized based on the specific population’s needs, targeting cognitive difficulties relevant to BD. Clear intervention objectives were defined, and the chosen session methodology was structured to support these outcomes. The intervention followed a bio-psycho-social theoretical model, integrating various techniques to address multiple variables, from cognitive to psycho-social aspects, ultimately promoting the generalization of trained skills and long-term effects. Previous publications provide a detailed explanation of the session methodologies designed to enhance the reproducibility of the intervention.

2.5. Statistical Analysis

The data were analyzed using SPSS software (version 21). Descriptive statistics (means ± SD) were calculated for each outcome at T0, T1, T2, and T3. Cognitive variables scores were adjusted using normative data corrected for age and education level, with equivalent scores (0–4) used when available. The sample distribution was assessed using the Kolmogorov–Smirnov test for normality. As the data did not follow a normal distribution across the different time points, the Friedman test was applied.

3. Results

Thirty-four participants in the experimental VR-CR group completed both the 6- and 12-month follow-up assessments post-intervention and were included in the analysis. The dropout rate was 32% at both follow-ups. Table 1 presents descriptive statistics for the outcomes assessed at T0, T1, T2, and T3. According to the Kolmogorov–Smirnov test for distribution analysis, only the Rey Immediate Figure, Matrix Test, Substitute Symbol Digit Test, and Test of Tale followed a normal distribution across all time points. All the other tests did not follow a normal distribution at the four evaluation time points.
Overall, the cognitive variables showed a trend toward stability or improvement over time (p > 0.05). The Verbal Phonological/Semantic Test (language function) demonstrated significant improvement (p < 0.05) over time (Table 2). However, the Cognitive Estimation Test (executive functions) and the Rey Immediate Figure (visuospatial function) exhibited less clear patterns, with significant changes over time (p = 0.00; p = 0.01) but no consistent directional trend (Table 1 and Table 2).

4. Discussion

This study aimed to provide preliminary evidence of the sustained improvement in cognitive functions among individuals with BD who participated in a fully immersive VR-CR program when assessed at 6 and 12 months post-intervention. Consistent with our hypothesis, the findings indicated overall stability in cognitive function improvements over time. Additionally, the long-term dropout rate was in line with that of previous studies (Zhu et al., 2022). For this study, we selected software that allowed for the training of various cognitive functions in everyday life contexts. This decision was based on an analysis of the specific needs of individuals with BD (Carta et al., 2023a; Perra et al., 2023a) and previous literature (Cella et al., 2015; Tsapekos et al., 2023). Reeder et al., 2017; Freeman et al., 2019). A structured CR intervention methodology was also adopted, aligning with biopsychosocial models and recovery-oriented approaches (Perra et al., 2022; Saxena et al., 2022).
The intervention consisted of two sessions per week over a three-month period. Strategies were implemented to facilitate the transfer of skills to daily life, including personalized homework assignments. Additional techniques, such as massed practice, metacognitive strategies, mindfulness exercises, and psychoeducation, were incorporated to reinforce the skills being developed. The results of this study, consistent with both the intervention methodology and theoretical framework, demonstrated good feasibility over time and provided preliminary evidence supporting the stability of cognitive function improvements, particularly in semantic and verbal language functions. Clinically, these findings suggest that VR-based CR interventions could be integrated into existing treatment plans for individuals with BD to enhance cognitive functioning and support long-term recovery. Clinicians might consider using VR-CR as a supplementary tool to traditional cognitive therapies, particularly for improving cognitive skills in real-life contexts. Given the observed stability of improvements at 6 and 12 months, VR-CR could help individuals with BD maintain cognitive gains and apply them to everyday activities, ultimately improving personal and social functioning. Moreover, the inclusion of psychoeducation and metacognitive strategies could enhance the therapeutic process by addressing both the cognitive and emotional aspects of functioning.
However, there were several limitations to consider in this study. First, due to the crossover design, it was not possible to compare the experimental group with a control group. While this design increased the statistical power and ensured that all the participants received the experimental treatment, it limited the ability to evaluate the long-term effects in a control group. Additionally, as this was a feasibility study, the results—despite the use of multivariate analysis to compare groups over time—require confirmation in future research. Despite these limitations, feasibility studies are valuable in assessing whether an intervention shows preliminary evidence of improving clinical and psychosocial outcomes. Such findings help refine intervention strategies and inform future research on the development of complex psychiatric rehabilitation programs using VR. This study provides valuable insights that should be further explored in effectiveness trials with larger samples and more advanced statistical analyses. An important direction for future research is to examine the impact of neurological diseases, such as multiple sclerosis, and the role of co-occurring anxiety symptoms on cognitive functioning in BD (Kosmidis et al., 2012; Giannouli, 2017; Filser et al., 2023). In the present study, this analysis was not possible due to the low prevalence of these neurological comorbidities in the sample, which did not allow for the identification of specific subgroups. Additionally, future follow-up studies, including a control group, are necessary to confirm the long-term effects on cognitive and psychosocial functioning.

5. Conclusions

The fully immersive VR-CR program appears to be a promising tool for individuals with BD, with potential long-term benefits for visuospatial abilities, verbal and semantic fluency, and executive functioning. To ensure the sustained impact of these clinical outcomes, an integrated approach is crucial, incorporating psychoeducational strategies within cognitive remediation interventions.
A key strength of this study is the use of advanced VR technology, which enhances engagement in psychosocial rehabilitation programs. Furthermore, the study highlights long-term outcomes, a critical aspect for the sustainability of mental health rehabilitation interventions. These findings, along with previously published data, underscore the importance of further investigation given the program’s feasibility and the preliminary evidence of post-treatment stability at 6 and 12 months.

Author Contributions

Conceptualization, M.G.C. and A.P. (Alessandra Perra); methodology, M.G.C., A.P. (Alessandra Perra), D.P., V.D.L. and F.S.; software, V.D.L. and L.D.N.; formal analysis, A.P. (Antonio Preti) and F.S.; investigation, R.Z., A.G., A.L. and F.P.; resources, M.G.C. and A.P. (Alessandra Perra); data curation, G.C.; writing—original draft preparation, A.P. (Alessandra Perra) and F.S.; writing—review and editing, A.P. (Alessandra Perra), S.M., M.G.C., V.D.L., R.Z., A.G., A.L., F.P., A.P., D.P., L.D.N., A.E.N., G.C. and F.S.; supervision, M.G.C., A.P. (Alessandra Perra), S.M., A.E.N. and V.D.L.; project administration, M.G.C.; funding acquisition, M.G.C. and A.P. (Alessandra Perra). All authors have read and agreed to the published version of the manuscript.

Funding

The study was financially supported by Fondazione di Sardegna (U351.2020/AI.334.MGB-2020.1581). However, the funding source played no part in the study’s design (including the data collection, analysis, and interpretation), drafting of the report, or determination to submit and publish its findings.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki (World Medical Association, 2013), and approved by the Local Independent Ethics Committee (Prot. PG/2020/2168).

Informed Consent Statement

Informed consent was obtained from all the participants involved in the study.

Data Availability Statement

Data sharing is not applicable to this article.

Conflicts of Interest

One of the authors (LDN) serves as the legal representative of the organizations responsible for developing the CEREBRUM software and VDL is the scientific director of the company.

Abbreviations

The following abbreviations are used in this manuscript:
CRCognitive Remediation
VRVirtual Reality
BDBipolar Disorder
CICognitive Impairment
CONSORTConsolidated Standards of Reporting Trial
FABFrontal Assessment Battery
CESCognitive Estimates Test

References

  1. Abdulatif, M., Mukhtar, A., & Obayah, G. (2015). Pitfalls in reporting sample size calculation in randomized controlled trials published in leading anaesthesia journals: A systematic review. British Journal of Anaesthesia, 115(5), 699–707. [Google Scholar] [CrossRef] [PubMed]
  2. Amodio, P., Campagna, F., Olianas, S., Iannizzi, P., Mapelli, D., Penzo, M., Angeli, P., & Gatta, A. (2008). Detection of minimal hepatic encephalopathy: Normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. Journal of Hepatology, 49(3), 346–353. [Google Scholar]
  3. Amodio, P., Wenin, H., Del Piccolo, F., Mapelli, D., Montagnese, S., Pellegrini, A., Musto, C., Gatta, A., & Umiltà, C. (2002). Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clinical and Experimental Research, 14(2), 117–131. [Google Scholar] [CrossRef] [PubMed]
  4. Bernabei, L., Bersani, F. S., Pompili, E., Chiaie, R. D., Valente, D., Corrado, A., Vergnani, L., Ferracuti, S., Biondi, M., & De’Fornari, M. A. C. (2020). Cognitive remediation for the treatment of neuropsychological disturbances in subjects with euthymic bipolar disorder: Findings from a controlled study. Journal of Affective Disorders, 273, 576–585. [Google Scholar] [CrossRef] [PubMed]
  5. Bisiacchi, P. S., Mapelli, D., Mondini, S., & Vestri, A. (2003). Esame neuropsicologico breve, una batteria di test per lo screening neuropsicologico. Raffaello Cortina Editore. [Google Scholar]
  6. Bortolato, B., Miskowiak, K. W., Köhler, C. A., Vieta, E., & Carvalho, A. F. (2015). Cognitive dysfunction in bipolar disorder and schizophrenia: A systematic review of meta-analyses. Neuropsychiatric Disease and Treatment, 11, 3111–3125. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  7. Caffarra, P., Vezzadini, G., Dieci, F., Zonato, F., & Venneri, A. (2002a). Rey-Osterrieth complex figure: Normative values in an Italian population sample. Neurological Sciences, 22(6), 443–447. [Google Scholar] [CrossRef]
  8. Caffarra, P., Vezzadini, G., Dieci, F., Zonato, F., & Venneri, A. (2002b). Una versione abbreviata del test di Stroop: Dati normativi nella popolazione italiana. Nuova Rivista di Neurologia, 12, 111–115. [Google Scholar]
  9. Caltagirone, C., Gainotti, G., Carlesimo, G. A., & Parnetti, L. (1995). Batteria per la valutazione del deterioramento mentale: I. Descrizione di uno strumento di diagnosi neuropsicologica. Archivio di Psicologia, Neurologia e Psichiatria, 14, 109–138. [Google Scholar]
  10. Carlesimo, G. A., Buccione, I., Fadda, L., Graceffa, A., Mauri, M., Lorusso, S., & Caltagirone, C. (2002). Standardizzazione di due test dimemoria per uso clinico: Breve racconto e figura di rey. Nuova Rivista di Neurologia, 12, 1–13. [Google Scholar]
  11. Carta, M. G., Kalcev, G., Fornaro, M., Pinna, S., Gonzalez, C. I. A., Nardi, A. E., & Primavera, D. (2023a). Does screening for bipolar disorders identify a “Dysregulation of Mood, Energy, and Social Rhythms Syndrome” (DYMERS)? A heuristic working hypothesis. Journal of Clinical Medicine, 12(15), 5162. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  12. Carta, M. G., Kalcev, G., Scano, A., Gonzalez, C. I. A., Ouali, U., Pinna, S., Carrà, G., Romano, F., Preti, A., Orrù, G., Minerba, L., Cossu, G., Nardi, A. E., & Primavera, D. (2023b). The impact of MDQ positivity on quality of life impairment: Does it support the hypothesis of “Dysregulation of Mood, Energy, and Social Rhythms Syndrome” (DYMERS)? Journal of Public Health Research, 12(4), 22799036231208356. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  13. Carta, M. G., Kalcev, G., Scano, A., Pinna, S., Gonzalez, C. I. A., Nardi, A. E., Orrù, G., & Primavera, D. (2023c). Screening, genetic variants, and bipolar disorders: Can useful hypotheses arise from the sum of partial failures? Clinics and Practice, 13(4), 853–862. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  14. Carta, M. G., Kalcev, G., Scano, A., Primavera, D., Orrù, G., Gureye, O., Cossu, G., & Nardi, A. E. (2022). Is bipolar disorder the consequence of a genetic weakness or not having correctly used a potential adaptive condition? Brain Sciences, 13(1), 16. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  15. Carta, M. G., Ouali, U., Perra, A., Ahmed, A. B. C., Boe, L., Aissa, A., Lorrai, S., Cossu, G., Aresti, A., Preti, A., & Nacef, F. (2021). Living with bipolar disorder in the time of COVID-19: Biorhythms during the severe lockdown in Cagliari, Italy, and the moderate lockdown in Tunis, Tunisia. Frontiers in Psychiatry, 12, 634765. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  16. Cella, M., Preti, A., Edwards, C., Dow, T., & Wykes, T. (2017). Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis. Clinical Psychology Review, 52, 43–51. [Google Scholar] [CrossRef] [PubMed]
  17. Cella, M., Reeder, C., & Wykes, T. (2015). Lessons learnt? The importance of metacognition and its implications for Cognitive Remediation in schizophrenia. Frontiers in Psychology, 6, 1259. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  18. Della Sala, S., MacPherson, S. E., Phillips, L., Sacco, L., & Spinnler, H. (2003). How many camels are there in Italy? Cognitive estimates standardised on the Italian population. Neurological Sciences, 24(1), 10–15. [Google Scholar] [CrossRef]
  19. Deste, G., Barlati, S., Cacciani, P., DePeri, L., Poli, R., Sacchetti, E., & Vita, A. (2015). Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. Schizophrenia Research, 161(2–3), 403–406. [Google Scholar] [CrossRef] [PubMed]
  20. Douglas, K. M., Gallagher, P., Robinson, L. J., Carter, J. D., McIntosh, V. V., Frampton, C. M., Watson, S., Young, A. H., Ferrier, I. N., & Porter, R. J. (2018). Prevalence of cognitive impairment in major depression and bipolar disorder. Bipolar Disorders, 20(3), 260–274. [Google Scholar] [CrossRef] [PubMed]
  21. Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. F. A. B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626. [Google Scholar] [CrossRef]
  22. Ehrlich, T. J., Ryan, K. A., Burdick, K. E., Langenecker, S. A., McInnis, M. G., & Marshall, D. F. (2022). Cognitive subgroups and their longitudinal trajectories in bipolar disorder. Acta Psychiatrica Scandinavica, 146(3), 240–250. [Google Scholar] [CrossRef] [PubMed]
  23. Ehrminger, M., Brunet-Gouet, E., Cannavo, A. S., Aouizerate, B., Cussac, I., Azorin, J. M., Bellivier, F., Bougerol, T., Courtet, P., Dubertret, C., Etain, B., Kahn, J., Leboyer, M., Olié, E., FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators, Passerieux, C., & Roux, P. (2021). Longitudinal relationships between cognition and functioning over 2 years in euthymic patients with bipolar disorder: A cross-lagged panel model approach with the FACE-BD cohort. The British Journal of Psychiatry, 218(2), 80–87. [Google Scholar] [CrossRef] [PubMed]
  24. Eldridge, S. M., Chan, C. L., Campbell, M. J., Bond, C. M., Hopewell, S., Thabane, L., & Lancaster, G. A. (2016). CONSORT 2010 statement: Extension to randomised pilot and feasibility trials. BMJ, 355, i5239. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  25. Filser, M., Buchner, A., Fink, G. R., Gold, S. M., & Penner, I. (2023). The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools. Journal of Neurology, 270(1), 171–207. [Google Scholar] [CrossRef] [PubMed]
  26. Fiorillo, A., & Giordano, A. (2022). The biopsychosocial model of schizophrenia and cancer: Unraveling the etiopathogenesis of complex diseases. European Psychiatry, 65(1), 1–5. [Google Scholar] [CrossRef]
  27. Freeman, D., Lister, R., Waite, F., Yu, L., Slater, M., Dunn, G., & Clark, D. (2019). Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: Study protocol for a single-blind parallel-group randomised controlled trial (THRIVE). Trials, 20(1), 87. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  28. Freeman, D., Reeve, S., Robinson, A., Ehlers, A., Clark, D., Spanlang, B., & Slater, M. (2017). Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychological Medicine, 47(14), 2393–2400. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  29. Giannouli, V. (2017). Insomnia-related sleep disruptions, cognition and detailed concurrent anxiety testing during the inter-episode phase of bipolar disorder: A Herculean task or a necessity? Journal of Psychiatric Research, 95, 76–77. [Google Scholar] [CrossRef]
  30. Giovagnoli, A. R., Del Pesce, M., Mascheroni, S., Simoncelli, M., Laiacona, M., & Capitani, E. (1996). Trail making test: Normative values from 287 normal adult controls. The Italian Journal of Neurological Sciences, 17(4), 305–309. [Google Scholar] [CrossRef]
  31. Goldberg, Z., Kuslak, B., & Kurtz, M. M. (2023). A meta-analytic investigation of cognitive remediation for mood disorders: Efficacy and the role of study quality, sample and treatment factors. Journal of Affective Disorders, 330, 74–82. [Google Scholar] [CrossRef]
  32. Huddy, V., Reeder, C., Kontis, D., Wykes, T., & Stahl, D. (2012). The effect of working alliance on adherence and outcome in cognitive remediation therapy. Journal of Nervous & Mental Disease, 200(7), 614–619. [Google Scholar] [CrossRef] [PubMed]
  33. Kosmidis, M. H., Bozikas, V. P., Giannouli, V., Karavatos, A., & Fokas, K. (2012). Familial comorbidity of bipolar disorder and multiple sclerosis: Genetic susceptibility, coexistence or causal relationship? Behavioural Neurology, 25(4), 341–349. [Google Scholar] [CrossRef] [PubMed]
  34. Lewandowski, K. E., Sperry, S. H., Cohen, B. M., Norris, L. A., Fitzmaurice, G. M., Ongur, D., & Keshavan, M. S. (2017). Treatment to enhance cognition in bipolar disorder (TREC-BD): Efficacy of a randomized controlled trial of cognitive remediation versus active control. The Journal of Clinical Psychiatry, 78(9), e1242–e1249. [Google Scholar] [CrossRef]
  35. Lima, F., Rabelo-da-Ponte, F. D., Bücker, J., Czepielewski, L., Hasse-Sousa, M., Telesca, R., Solé, B., Reinares, M., Vieta, E., & Rosa, A. R. (2019). Identifying cognitive subgroups in bipolar disorder: A cluster analysis. Journal of Affective Disorders, 246, 252–261. [Google Scholar] [CrossRef]
  36. Miskowiak, K. W., Burdick, K. E., Martinez-Aran, A., Bonnin, C., Bowie, C. R., Carvalho, A. F., Gallagher, P., Lafer, B., López-Jaramillo, C., Sumiyoshi, T., McIntyre, R. S., Schaffer, A., Porter, R. J., Torres, I. J., Yatham, L. N., Young, A. H., Kessing, L. V., & Vieta, E. (2017). Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disorders, 19(8), 614–626. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  37. Novelli, G., Papagno, C., Capitani, E., & Laiacona, M. (1986). Tre test clinici di ricerca e produzione lessicale. Taratura su sogetti normali. Archivio di Psicologia, Neurologia e Psichiatria, 47, 477–506. [Google Scholar]
  38. Orsini, A., Grossi, D., Capitani, E., Laiacona, M., Papagno, C., & Vallar, G. (1987). Verbal and spatial immediate memory span: Normative data from 1355 adults and 1112 children. The Italian Journal of Neurological Sciences, 8(6), 537–548. [Google Scholar] [CrossRef]
  39. Ott, C. V., Macoveanu, J., Bowie, C. R., Fisher, P. M., Knudsen, G. M., Kessing, L. V., & Miskowiak, K. W. (2021). Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: A randomized controlled trial. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 46(6), 1113–1121. [Google Scholar] [CrossRef]
  40. Perra, A., De Lorenzo, V., Zaccheddu, R., Locci, A., Piludu, F., Preti, A., Di Natale, L., Galetti, A., Nardi, A. E., Cossu, G., Sancassiani, F., Barbato, S., Cesaretti, O., Kurotshka, P. K., & Carta, M. G. (2022). Cognitive remediation virtual reality tool a tecovery-oriented project for people with bipolar disorder: Protocol of a feasibility randomized clinical trial. Clinical Practice and Epidemiology in Mental Health, 18(1), e174501792208220. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  41. Perra, A., Galetti, A., Zaccheddu, R., Locci, A., Piludu, F., Preti, A., Primavera, D., Di Natale, L., Nardi, A. E., Kurotshka, P. K., Cossu, G., Sancassiani, F., Stella, G., De Lorenzo, V., Zreik, T., & Carta, M. G. (2023a). A recovery-oriented program for people with bipolar disorder through virtual reality-based cognitive remediation: Results of a feasibility randomized clinical trial. Journal of Clinical Medicine, 12(6), 2142. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  42. Perra, A., Riccardo, C. L., De Lorenzo, V., De Marco, E., Di Natale, L., Kurotschka, P. K., Preti, A., & Carta, M. G. (2023b). Fully immersive virtual reality-based cognitive remediation for adults with psychosocial disabilities: A systematic scoping review of methods intervention gaps and meta-analysis of published effectiveness studies. International Journal of Environmental Research and Public Health, 20(2), 1527. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  43. Reeder, C., Huddy, V., Cella, M., Taylor, R., Greenwood, K., Landau, S., & Wykes, T. (2017). A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): A randomised controlled trial. Psychological Medicine, 47(15), 2720–2730. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  44. Samamé, C. (2024). When wrong is assumed right: A response to vieta. Psychological Medicine, 54(12), 3567–3568. [Google Scholar] [CrossRef]
  45. Samamé, C., Durante, P., Cattaneo, B., Aprahamian, I., & Strejilevich, S. (2023). Efficacy of cognitive remediation in bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Psychological Medicine, 53(12), 5361–5373. [Google Scholar] [CrossRef] [PubMed]
  46. Saxena, A., Paredes-Echeverri, S., Michaelis, R., Popkirov, S., & Perez, D. L. (2022). Using the biopsychosocial model to guide patient-centered neurological treatments. Seminars in Neurology, 42(02), 080–087. [Google Scholar] [CrossRef]
  47. Scarpina, F., D’Aniello, G. E., Mauro, A., Castelnuovo, G., & MacPherson, S. E. (2015). How many segments are there in an orange: Normative data for the new Cognitive Estimation Task in an Italian population. Neurological Sciences, 36(10), 1889–1895. [Google Scholar] [CrossRef] [PubMed]
  48. Skivington, K., Matthews, L., Simpson, S. A., Craig, P., Baird, J., Blazeby, J. M., Boyd, K. A., Craig, N., French, D. P., McIntosh, E., Petticrew, M., Rycroft-Malone, J., White, M., & Moore, L. (2021). A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. BMJ, 374, n2061. [Google Scholar] [CrossRef]
  49. Spinnler, H., & Tognoni, G. (1987). Standardizzazione e taratura italiana di test neuropsicologici. Italian Journal of Neurological Sciences, 6, 21–120. [Google Scholar]
  50. Strawbridge, R., Tsapekos, D., Hodsoll, J., Mantingh, T., Yalin, N., McCrone, P., Boadu, J., Macritchie, K., Cella, M., Reeder, C., Fish, J., Wykes, T., & Young, A. H. (2021). Cognitive remediation therapy for patients with bipolar disorder: A randomised proof-of-concept trial. Bipolar Disorders, 23(2), 196–208. [Google Scholar] [CrossRef]
  51. Torrent, C., Bonnin, C. D. M., Martínez-Arán, A., Valle, J., Amann, B. L., González-Pinto, A., Crespo, J. M., Ibáñez, Á., Garcia-Portilla, M. P., Tabarés-Seisdedos, R., Arango, C., Colom, F., Solé, B., Pacchiarotti, I., Rosa, A. R., Ayuso-Mateos, J. L., Anaya, C., Fernández, P., Landín-Romero, R., … Vieta, E. (2013). Efficacy of functional remediation in bipolar disorder: A multicenter randomized controlled study. The American Journal of Psychiatry, 170(8), 852–859. [Google Scholar] [CrossRef]
  52. Tsapekos, D., Strawbridge, R., Cella, M., Young, A. H., & Wykes, T. (2023). Does cognitive improvement translate into functional changes? Exploring the transfer mechanisms of cognitive remediation therapy for euthymic people with bipolar disorder. Psychological Medicine, 53(3), 936–944. [Google Scholar] [CrossRef] [PubMed]
  53. Tsapekos, D., Strawbridge, R., Wykes, T., Young, A. H., & Cella, M. (2022). Cognitive remediation for people with bipolar disorder: The contribution of session attendance and therapy components to cognitive and functional outcomes. Journal of Psychiatric Research, 152, 144–151. [Google Scholar] [CrossRef] [PubMed]
  54. Valmaggia, L. (2017). The use of virtual reality in psychosis research and treatment. World Psychiatry, 16(3), 246–247. [Google Scholar] [CrossRef]
  55. Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews Disease Primers, 4(1), 18008. [Google Scholar] [CrossRef] [PubMed]
  56. Vinogradov, S., Fisher, M., & de Villers-Sidani, E. (2012). Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology, 37(1), 43–76. [Google Scholar] [CrossRef]
  57. Vita, A., Barlati, S., Ceraso, A., Nibbio, G., Ariu, C., Deste, G., & Wykes, T. (2021). Effectiveness, core elements, and moderators of response of cognitive remediation for schizophrenia: A systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry, 78(8), 848–858. [Google Scholar] [CrossRef]
  58. Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., Burstein, R., Murray, C. J., & Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The Lancet, 382(9904), 1575–1586. [Google Scholar] [CrossRef] [PubMed]
  59. World Medical Association. (2013). World medical association declaration of helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191–2194. [Google Scholar] [CrossRef] [PubMed]
  60. Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011). A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. American Journal of Psychiatry, 168(5), 472–485. [Google Scholar] [CrossRef]
  61. Zhu, X., Fan, H., Zou, Y., Tan, Y., Yang, F., Wang, Z., Zhao, Y., Fan, F., Reeder, C., Zhou, D., Tan, S., & Wykes, T. (2022). Computerized or manual? Long term effects of cognitive remediation on schizophrenia. Schizophrenia Research, 239, 47–54. [Google Scholar] [CrossRef] [PubMed]
Figure 1. CONSORT extension flow diagram for feasibility study. * refers to 21 participants that, due to the crossover methodology, were initially part of the control group. After the washout period they became part of the intervention group.
Figure 1. CONSORT extension flow diagram for feasibility study. * refers to 21 participants that, due to the crossover methodology, were initially part of the control group. After the washout period they became part of the intervention group.
Behavsci 15 00452 g001
Table 1. Cognitive test—descriptive analysis (mean and standard deviation).
Table 1. Cognitive test—descriptive analysis (mean and standard deviation).
VR/CR GROUP (N = 36)
TestT0T1T2T3
Fig. Rey Immediate (Vis. Sp.)29.04 ± 8.6030.68 ± 6.8828.11 ± 9.1328.83 ± 8.73
Matrix (Attent.)1.94 ± 1.372.36 ± 1.471.94 ± 1.411.88 ± 1.40
Digit Span Forward (Attent.)2.86 ± 1.472.75 ± 1.502.66 ± 1.532.75 ± 1.46
Rey’s Words Immediate (Attent.)2.38 ± 1.623.02 ± 1.502.66 ± 1.802.72 ± 1.75
TMT-A (Attent.)2.88 ± 1.213.02 ± 1.423.11 ± 1.183.16 ± 1.20
Rey’s Words Delayed (Memory)2.25 ± 1.572.89 ± 1.552.70 ± 1.722.75 ± 1.67
Digit Span Backward (Memory)1.97 ± 1.642.16 ± 1.682.15 ± 1.522.61 ± 1.49
Test of Tale (Memory)2.16 ± 1.442.77 ± 1.172.25 ± 1.152.52 ± 1.18
Verbal Phonological Test (Leng.)2.63 ± 1.433.05 ± 1.283.13 ± 1.373.11 ± 1.42
Verbal Semantic Test (Leng.)2.63 ± 1.313.22 ± 1.142.97 ± 1.342.97 ± 1.34
Substit. Digit Symbol (Ex. Fun.)35.9 ± 13.9738.55 ± 11.8937.81 ± 14.4538.56 ± 14.71
TMT-B (Ex. Fun.)2.91 ± 1.293.02 ± 1.203.08 ± 1.363.02 ± 1.34
Stroop Test Time (Ex. Fun.)2.61 ± 1.602.94 ± 1.452.83 ± 1.592.75 ± 1.61
FAB (Ex. Fun.)15.0 ± 3.2015.58 ± 2.6615.27 ± 2.9515.30 ± 2.92
Cognitive Estimation Test (Ex. Fun.)1.94 ± 1.472.80 ± 1.091.88 ± 1.361.88 ± 1.34
Table 2. Cognitive test—repeated measures Friedman’s test analysis.
Table 2. Cognitive test—repeated measures Friedman’s test analysis.
Testχ²p
Fig. Rey Immediate (Vis. Sp.)10.610.01
Matrix (Attent.)5.150.16
Digit Span Forward (Attent.)0.120.98
Rey’s Words Immediate (Attent.)6.120.10
TMT-A (Attent.)2.770.42
Ray’s Words Delayed (Memory)7.100.06
Digit Span Backward (Memory)4.500.21
Test of Tale (Memory)3.680.29
Verbal Phonological Test (Language)9.100.02
Verbal Semantic Test (Language)9.220.02
Substit. Digit Symbol (Ex. Fun.)0.660.88
TMT-B (Ex. Fun.)2.200.53
Stroop Test Time (Ex. Fun.)1.350.71
FAB (Ex. Fun.)1.090.77
Cognitive Estimation Test (Ex. Fun.)16.470.00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Perra, A.; Carta, M.G.; Primavera, D.; Cossu, G.; Locci, A.; Zaccheddu, R.; Piludu, F.; Galetti, A.; Preti, A.; De Lorenzo, V.; et al. An Integrated Cognitive Remediation and Recovery-Oriented Program for Individuals with Bipolar Disorder Using a Virtual Reality-Based Intervention: 6- and 12-Month Cognitive Outcomes from a Randomized Feasibility Trial. Behav. Sci. 2025, 15, 452. https://doi.org/10.3390/bs15040452

AMA Style

Perra A, Carta MG, Primavera D, Cossu G, Locci A, Zaccheddu R, Piludu F, Galetti A, Preti A, De Lorenzo V, et al. An Integrated Cognitive Remediation and Recovery-Oriented Program for Individuals with Bipolar Disorder Using a Virtual Reality-Based Intervention: 6- and 12-Month Cognitive Outcomes from a Randomized Feasibility Trial. Behavioral Sciences. 2025; 15(4):452. https://doi.org/10.3390/bs15040452

Chicago/Turabian Style

Perra, Alessandra, Mauro Giovanni Carta, Diego Primavera, Giulia Cossu, Aurora Locci, Rosanna Zaccheddu, Federica Piludu, Alessia Galetti, Antonio Preti, Valerio De Lorenzo, and et al. 2025. "An Integrated Cognitive Remediation and Recovery-Oriented Program for Individuals with Bipolar Disorder Using a Virtual Reality-Based Intervention: 6- and 12-Month Cognitive Outcomes from a Randomized Feasibility Trial" Behavioral Sciences 15, no. 4: 452. https://doi.org/10.3390/bs15040452

APA Style

Perra, A., Carta, M. G., Primavera, D., Cossu, G., Locci, A., Zaccheddu, R., Piludu, F., Galetti, A., Preti, A., De Lorenzo, V., Di Natale, L., Machado, S., Nardi, A. E., & Sancassiani, F. (2025). An Integrated Cognitive Remediation and Recovery-Oriented Program for Individuals with Bipolar Disorder Using a Virtual Reality-Based Intervention: 6- and 12-Month Cognitive Outcomes from a Randomized Feasibility Trial. Behavioral Sciences, 15(4), 452. https://doi.org/10.3390/bs15040452

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop